Earnings Per Share, Basic in USD/shares of UroGen Pharma Ltd. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
UroGen Pharma Ltd. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q3 2025.
  • UroGen Pharma Ltd. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.69 USD/shares, a 35.3% decline year-over-year.
  • UroGen Pharma Ltd. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -3 USD/shares, a 18.5% decline year-over-year.
  • UroGen Pharma Ltd. annual Earnings Per Share, Basic for 2024 was -2.96 USD/shares, a 16.6% increase from 2023.
  • UroGen Pharma Ltd. annual Earnings Per Share, Basic for 2023 was -3.55 USD/shares, a 26.2% increase from 2022.
  • UroGen Pharma Ltd. annual Earnings Per Share, Basic for 2022 was -4.81 USD/shares, a 3.02% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

UroGen Pharma Ltd. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3 -$1 $0 -35.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$3 -$1 $0 -28% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$3 -$1 $0 -5.75% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 -$3 -$1 $0 -11.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-10
Q3 2024 -$2 -$1 +$0.17 +25% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$3 -$1 +$0.21 +20.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$3 -$1 +$0.43 +33.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 -$3 -$1 +$0.53 +42.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-10
Q3 2023 -$4 -$1 +$0.45 +39.8% Jul 1, 2023 Sep 30, 2023 10-K 2025-03-10
Q2 2023 -$4 -$1 +$0.15 +12.7% Apr 1, 2023 Jun 30, 2023 10-K 2025-03-10
Q1 2023 -$4 -$1 $0 -4% Jan 1, 2023 Mar 31, 2023 10-K 2025-03-10
Q4 2022 -$4 -$1 +$0.02 +1.58% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$4 -$1 +$0.22 +16.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$5 -$1 $0 -0.86% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$5 -$1 $0 -6.84% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$4 -$1 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$1 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10

UroGen Pharma Ltd. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3 +$0.59 +16.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-10
2023 -$4 +$1.26 +26.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-10
2022 -$5 +$0.15 +3.02% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$5 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.